Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
-
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
-
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
-
Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer
-
ECARX Holdings Inc. Announces US$45.6 million Strategic Investment from Geely Holding Group
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
ESSL leading study to find where and why damaging hail is getting worse
-
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
-
Pet Valu Appoints Carmen Fortino and Matt Reindel to Board of Directors
-
FIS Launches Industry-First Offering Enabling Banks to Lead and Scale in Agentic Commerce
-
Olive Resource Capital Delivers Record Investment Performance in 2025; Provides Update on Investments for December 2025
-
Excellon Acquires Significant Exploration Property South of Tres Cerros
-
Tinka Provides Exploration Update on Huwaymidan Gold Project in Saudi Arabia Including Completion of 3,400-Metre RC Drill Program
-
ICG Silver & Gold Announces Closing of $1.5 Million Oversubscribed Private Placement and Provides Corporate Update
-
Gold X2 Mining Announces Agreement to Assume Option for Greenfields Target at Star Lake
-
Blue Sky Uranium Reports Positive Final Infill Drilling Results as It Advances Towards Prefeasibility-Feasibility Studies at Ivana Deposit, Amarillo Grande Project, Argentina
-
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
-
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
-
GreenLight Metals Announces U.S. Trading on the OTCQB Venture Market Under Symbol "GRLMF"
-
C3 Metals Restarts Full Exploration Activities in Jamaica Following Community Assistance Programs After Hurricane Melissa
-
GoGuardian Launches Hall Pass for Safer Hallways, More Classroom Learning
-
American Pacific Provides Update on Plan of Arrangement with ICG Silver & Gold Ltd. and Completes Share Payments to Three Former Employees
-
Helios HVACR deploys A.I. nationwide in partnership with Bluon
-
IN TWO WEEKS: Little Rock Students to Shine in School Choice Showcase
-
Gaming and Leisure Properties, Inc. Schedules Fourth Quarter 2025 Earnings Release and Conference Call
-
NexGold Provides Summary of 2025 Activities and Key Priorities for 2026
-
Canada’s Biggest Popcorn Celebration: Cineplex Expands National Popcorn Day to Four Days
-
P10 Announces Upcoming Name Change
-
KEY Investment Partners Acquires BellRock Brands’ Portfolio, Home of Mary’s Medicinals, Dixie and Other Top Names
-
RAD Increases Ownership in Radiopharm Ventures to 87.5%
-
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
-
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
-
Lyra Therapeutics Provides Corporate Update
-
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
-
Independence Power Holdings, Inc. Completes Business Combination/Reverse Merger with TriUnity Business Services; Addresses Permian Basin Power Shortfall with Software-Driven Microgrids
-
Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey, Mobilizes Stone Island VTEM Survey
-
Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
-
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2025
-
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
-
Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD
-
Golden Arrow Confirms Near-Surface Gold Zone with Trench Results including 76.7m @ 1.01 g/t Au at Noemi Gold Target, San Pietro Project, Chile
-
GTCR Completes Sale of Worldpay to Global Payments
-
Accredant Capital Advises Segue Sustainable Infrastructure on Sale of Community Solar Portfolio to Radial Power
-
A2Z Cust2Mate Expands into Toy Retail with Large-Scale Smart Cart Deployments
-
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
-
Avista-Backed WellSpring Consumer Healthcare Acquires Established OTC Skincare Brands, DerMend® and Recticare®
-
NEXT with Michael Sonnenfeldt Returns for Season 2, Featuring Visionary Entrepreneurs Shaping What Comes Next
-
Zumiez Inc. Reports Holiday 2025 Sales Results
-
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
-
Noodles & Company Announces Preliminary Revenue Results for the Fourth Quarter of 2025
